Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Kari C. Nadeau, MD, PhD

Nadissy Foundation Professor of Medicine and Pediatrics; Director of the Sean Parker Center for Allergy and Asthma Research at Stanford University
Stanford University
Palo Alto, CA, United States

Dr. Kari Nadeau is the Naddisy Foundation Professor of Medicine and Pediatrics and, Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She is Section Chief in Asthma and Allergy in Pulmonary and Critical Care at Stanford. She is a pediatrician and practices Allergy, Asthma, Immunology in both children and adults.

For more than 30 years, she has devoted herself to understanding how environmental and immune/genetic factors affect allergies, immune tolerance, and asthma. As a world-renowned adult and pediatric immunologist, she has been invited as the keynote speaker for international organizations all around the world presenting talks related to allergy, asthma, immunology, COVID-19 vaccinations, and the Sean N. Parker Center’s clinical studies. Dr. Nadeau, an expert in the field, has pioneered and discovered the mechanism of new therapies to make the transformative changes in patients dealing with food allergens and allergies to help find cures. Her research is laying the groundwork for a variety of potential future therapies to prevent and cure allergies and asthma.

Over the past decades, Dr. Nadeau has started four companies dealing with food allergy and has eight patents as the inventor: Before Brands (2016), Latitude (2018), Alladapt (2020), and IgGenix (2020). She is a member of many advisory boards of biotechnology companies in immunology, autoimmune disease, allergies, and asthma. Amidst the pandemic and wildfires, Dr. Nadeau launched a book at the end of September 2020. She is the co-author of The End of Food Allergy along with Sloan Barnett, a lawyer and bestselling author, to explore preventing, treating, and reversing food allergies. More recently, she has worked on global climate change and health, air pollution, wildfires, emergency preparedness, molecular biomarkers, clinical research trials, mechanisms of prevention in food, diet, and microbiome science. With the global pandemic that impacted us all, she dove deep into extensive research with COVID and its long-term consequences to further our understanding in the novel coronavirus.

Dr. Nadeau has been an influential leader, an unstoppable force to establish change, and supportive with woman initiative. She thrives and deeply commits her time to mentoring those around her, help the underserved communities, environmental climate changes, and global health for women. Everywhere Dr. Nadeau goes, she makes an impact to the people around her.

This past year, she had led key clinical trials in COVID (remdesivir) to receive FDA approval, in COVID vaccines (she and her lab discovered what was causing the allergies to the vaccine), launched her book (The End of Food Allergies in over 10 languages) across the globe, helped in getting prevention products to more infants throughout the world, and found new therapies and diagnostics for food allergies.

https://profiles.stanford.edu/kari-nadeau

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):